Patient Rating
Patients describe Dr. Branch as knowledgeable, calm, and caring with a strong bedside manner. Many note that he listens, involves patients in decision-making, and explains diagnostic reasoning and current research to create clear, personalized care plans. Reviewers appreciate his proactive approach and efforts to reassure and empower patients during appointments.
Generated via Patient Reviews
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
Board Certification and Academic Information
| Academic Departments |
Obstetrics & Gynecology
-Professor |
|---|---|
| Academic Divisions |
Maternal Fetal Medicine
|
Education history
| Fellowship | Maternal/Fetal Medicine - University of Utah School of Medicine | Fellow |
|---|---|---|
| Residency | OB/GYN - Medical College of Virginia Hospital | Resident |
| Internship | OB/GYN - Medical College of Virginia Hosp. | Intern |
| Professional Medical | Medicine - Medical College of Virginia | M.D. |
| Undergraduate | Biology - University of Richmond | B.S. |
Selected Publications
Journal Article
- Barbhaiya M, Zuily S, Jannat-Khah D, Amigo MC, Andrade D, Avcin T, Bertolaccini ML, Branch DW, Costedoat-Chalumeau N, de Jess GR, Devreese KMJ, Garcia D, Gomez Puerta JA, Guillemin F, Levine SR, Levy RA, Lockshin MD, Ortel TL, Petri M, Sanna G, Sciascia S, Seshan SV, Tektonidou M, Wahl D, Willis R, Yelnik C, Hendry A, Naden R, Costenbader KH, Erkan D, New APS Classification Criteria Collaborators (2026). Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of Definitions. Arthritis Care Res (Hoboken), 78(5), 563-573.
- Bruno AM, Job KM, Rower JE, Allshouse AA, Zinkhan EK, Lim MY, Shakib JH, Federspiel JJ, Watt KM, Metz TD, Branch DW (2025). Prophylactic-Dose Rivaroxaban Transfer Into Human Milk. Obstet Gynecol, 147(5), e116-e119.
- Thaler J, Parides M, de Andrade DCO, Ruiz DP, Tektonidou MG, Pengo V, Sciascia S, Nalli C, de Jess G, Fortin PR, Efthymiou M, Belmont HM, Petri M, Cervera R, Skeith L, Atsumi T, Lpez-Pedrera C, Zuo Y, Branch DW, Willis R, Kello N, Zhang Z, Almaraz ER, Artim-Esen B, Pardos-Gea J, Pons-Estel G, Pazzola G, Shi H, Duarte-Garcia A, Barbhaiya M, Yelnik C, Meroni P, Roubey R, Bertolaccini ML, Cohen H, Rand JH, Erkan D (2025). Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository ('Registry'). Ann Rheum Dis, 85(3), 497-506.
- Workalemahu T, Madsen MJ, Lopez S, Page JM, Blue NR, Avery C, Sargent R, Yu Z, Guinto E, Branch DW, Leisher S, Jorde LB, Quinlan A, Coon H, Varner MW, Roberts CT, Neklason DW, Camp NJ, Silver RM (2025). Inherited genetic risk in stillbirth: A shared genomic segments analysis of high-risk pedigrees. HGG Adv, 7(1), 100546.
- Bruno AM, Allshouse AA, Branch DW, Silver RM, Metz TD (2025). Low Molecular Weight Heparin Thromboprophylaxis or No Treatment following Cesarean Delivery: A Pilot Randomized Controlled Trial. Am J Perinatol.
- Pine A, Butt A, Andreoli L, Knight JS, Gerosa M, Cecchi I, Branch DW, Lopez-Pedrera R, Belmont HM, Kello N, Petri M, Cervera R, Pengo V, Meroni PL, Cohen H, Willis R, Bertolaccini ML, Goshua G, Gu S, Hwa J, Lee AI, Erkan D, Sharda AV (2025). A proteomic map of thromboinflammatory signatures in antiphospholipid syndrome: results from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) registry. Front Immunol, 16, 1676578.
- Branch DW, Kim MY, Guerra MM, Worden J, Laskin CA, DeSancho MT, Landres IV, Knight JS, Slosberg HS, Minett M, Salmon JE (2025). Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial. Ann Rheum Dis, 84(6), 1011-1022.
- Yelnik CM, Erton ZB, Drumez E, Cheildze D, de Andrade D, Clarke A, Tektonidou MG, Sciascia S, Pardos-Gea J, Pengo V, Ruiz-Irastorza G, Belmont HM, Pedrera CL, Fortin PR, Wahl D, Gerosa M, Kello N, Signorelli F, Atsumi T, Ji L, Efthymiou M, Branch DW, Nalli C, Rodriguez-Almaraz E, Petri M, Cervera R, Shi H, Zuo Y, Artim-Esen B, Pons-Estel G, Willis R, Barber MRW, Skeith L, Bertolaccini ML, Cohen H, Roubey R, Erkan D (2023). Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository ("Registry"). Semin Arthritis Rheum, 65, 152347.
- Lim MY, Rodgers GM, Branch DW, Simonsen SE (2024). Targeting a higher plasma VWF level at time of delivery in pregnant individuals with von Willebrand disease: Outcomes at a single-institution cohort study. Haemophilia, 30(2), 470-477.
- Branch DW, Lim MY (2023). How I diagnose and treat antiphospholipid syndrome in pregnancy. Blood, 143(9), 757-768.
- Zhu H, Lu D, Branch DW, Troendle J, Tang Y, Bernitz S, Zamora J, Betran AP, Zhou Y, Zhang J (2023). Oxytocin is not associated with postpartum hemorrhage in labor augmentation in a retrospective cohort study in the United States. Am J Obstet Gynecol, 230(2), 247.e1-247.e9.
- Bruno AM, Allshouse AA, Benson AE, Yost CC, Metz TD, Varner MW, Silver RM, Branch DW (2023). Thrombotic Markers in Pregnant Patients with and without SARS-CoV-2 Infection. Am J Perinatol, 41(S 01), e3202-e3209.
- Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, Amoura Z, Andrade D, Andreoli L, Artim-Esen B, Atsumi T, Avcin T, Belmont HM, Bertolaccini ML, Branch DW, Carvalheiras G, Casini A, Cervera R, Cohen H, Costedoat-Chalumeau N, Crowther M, de Jesus G, Delluc A, Desai S, De Sancho M, Devreese KM, Diz-Kucukkaya R, Duarte-Garcia A, Frances C, Garcia D, Gris JC, Jordan N, Leaf RK, Kello N, Knight JS, Laskin C, Lee AI, Legault K, Levine SR, Levy RA, Limper M, Lockshin MD, Mayer-Pickel K, Musial J, Meroni PL, Orsolini G, Ortel TL, Pengo V, Petri M, Pons-Estel G, Gomez-Puerta JA, Raimboug Q, Roubey R, Sanna G, Seshan SV, Sciascia S, Tektonidou MG, Tincani A, Wahl D, Willis R, Yelnik C, Zuily C, Guillemin F, Costenbader K, Erkan D, ACREULAR APS Classification Criteria Collaborators (2023). The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Arthritis Rheumatol, 75(10), 1687-1702.
- Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, Amoura Z, Andrade D, Andreoli L, Artim-Esen B, Atsumi T, Avcin T, Belmont HM, Bertolaccini ML, Branch DW, Carvalheiras G, Casini A, Cervera R, Cohen H, Costedoat-Chalumeau N, Crowther M, de Jess G, Delluc A, Desai S, Sancho M, Devreese KM, Diz-Kucukkaya R, Duarte-Garca A, Frances C, Garcia D, Gris JC, Jordan N, Leaf RK, Kello N, Knight JS, Laskin C, Lee AI, Legault K, Levine SR, Levy RA, Limper M, Lockshin MD, Mayer-Pickel K, Musial J, Meroni PL, Orsolini G, Ortel TL, Pengo V, Petri M, Pons-Estel G, Gomez-Puerta JA, Raimboug Q, Roubey R, Sanna G, Seshan SV, Sciascia S, Tektonidou MG, Tincani A, Wahl D, Willis R, Yelnik C, Zuily C, Guillemin F, Costenbader K, Erkan D, ACREULAR APS Classification Criteria Collaborators (2023). 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis, 82(10), 1258-1270.
- Parks AL, Fazili M, Aston V, Porter TF, Branch DW, Woller SC, Snow GL, Stevens SM (2023). Excluding pregnancy-associated deep vein thrombosis with whole-leg ultrasound. Res Pract Thromb Haemost, 7(7), 102202.
- Zuo Y, Navaz S, Tsodikov A, Kmetova K, Kluge L, Ambati A, Hoy CK, Yalavarthi S, de Andrade D, Tektonidou MG, Sciascia S, Pengo V, Ruiz-Irastorza G, Belmont HM, Gerosa M, Fortin PR, de Jesus GR, Branch DW, Andreoli L, Rodriguez-Almaraz E, Petri M, Cervera R, Willis R, Karp DR, Li QZ, Cohen H, Bertolaccini ML, Erkan D, Knight JS, Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (2023). Anti-Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody-Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository. Arthritis Rheumatol, 75(8), 1407-1414.
- Branch DW, VanBuren JM, Porter TF, Holmgren C, Holubkov R, Page K, Burchard J, Lam GK, Esplin MS (2021). Prediction and Prevention of Preterm Birth: A Prospective, Randomized Intervention Trial. Am J Perinatol, 40(10), 1071-1080.
- Balbi GGM, Ahmadzadeh Y, Tektonidou MG, Pengo V, Sciascia S, Ugarte A, Belmont HM, Lopez-Pedrera C, Fortin PR, Wahl D, Gerosa M, de Jess GR, Ji L, Atsumi T, Efthymiou M, Branch DW, Nalli C, Almaraz ER, Petri M, Cervera R, Knight JS, Artim-Esen B, Willis R, Bertolaccini ML, Cohen H, Roubey R, Erkan D, Andrade D, AntiPhospholipid Syndrome Alliance for Clinical Trials and International Networking APS ACTION Clinical Database and Repository APS ACTION (2023). Damage measured by damage index for antiphosphlipid syndrome in antiphospholipid antibody-positive patients included in APS ACTION Registry. Rheumatology (Oxford).
- Chighizola CB, Pregnolato F, Andrade D, Tektonidou M, Pengo V, Ruiz-Irastorza G, Belmont HM, Gerosa M, Fortin P, Branch DW, Andreoli L, Petri MA, Cervera R, Knight JS, Willis R, Efthymiou M, Cohen H, Erkan D, Bertolaccini ML, Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking APS ACTION (2023). Fluctuation of Anti-Domain 1 and Anti-β(2) -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies. Arthritis Rheumatol, 75(6), 984-995.
- Gkrouzman E, Willis R, Andrade D, Tektonidou MG, Pengo V, Ruiz-Irastorza G, Belmont HM, Fortin PR, Gerosa M, Signorelli F, Atsumi T, Branch DW, Nalli C, Rodriguez-Almaraz E, Petri MA, Cervera R, Knight JS, Efthymiou M, Cohen H, Bertolaccini ML, Erkan D, Roubey R, APS ACTION (2023). Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study. Lab Invest, 103(6), 100147.
- Dude AM, Smid MC, Branch DW, West J, Meeks H, Yu Z, Fraser A, Smith K, Reddy D (2021). Interpregnancy Body Mass Index Change and Offspring Mortality Risk following the Second Pregnancy. Am J Perinatol, 40(4), 387-393.
- Einerson BD, Kennedy A, Silver RM, Branch DW, Comstock J, Woodward PJ (2023). Ultrasonography of the Explanted Uterus in Placenta Accreta Spectrum: Correlation With Intraoperative Findings and Gross Pathology. Obstet Gynecol, 141(3), 544-554.
- Workalemahu T, Avery C, Lopez S, Blue NR, Wallace A, Quinlan AR, Coon H, Warner D, Varner MW, Branch DW, Jorde LB, Silver RM (2023). Whole-genome sequencing analysis in families with recurrent pregnancy loss: A pilot study. PLoS One, 18(2), e0281934.
- Mehta B, Jannat-Khah D, Glaser KK, Luo Y, Sammaritano LR, Branch DW, Goodman SM, Lockshin M, Wang F, Ibrahim S, Salmon JE (2022). Fetal and maternal morbidity in pregnant patients with Lupus: a 10-year US nationwide analysis. RMD Open, 9(1).
- Young A, Lim MY, Sanders J, Branch DW, Simonsen SE (2022). Pregnancy and childbirth in women with bleeding disorders: A retrospective cohort study. Haemophilia, 29(1), 240-247.
- Lim MY, Abou-Ismail MY, Branch DW (2022). Differentiating and Managing Rare Thrombotic Microangiopathies During Pregnancy and Postpartum. Obstet Gynecol, 141(1), 85-108.
- Scaglione MA, Allshouse AA, Canfield DR, Mclaughlin HD, Bruno AM, Hammad IA, Branch DW, Maurer KA, Dood RL, Debbink MP, Silver RM, Einerson BD (2022). Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta Spectrum. Obstet Gynecol, 140(5), 806-811.
- Bruno AM, Allshouse AA, Campbell HM, Branch DW, Lim MY, Silver RM, Metz TD (2022). Weight-Based Compared With Fixed-Dose Enoxaparin Prophylaxis After Cesarean Delivery: A Randomized Controlled Trial. Obstet Gynecol, 140(4), 575-583.
- Erton ZB, Sevim E, de Jess GR, Cervera R, Ji L, Pengo V, Ugarte A, Andrade D, Andreoli L, Atsumi T, Fortin PR, Gerosa M, Zuo Y, Petri M, Sciascia S, Tektonidou MG, Aguirre-Zamorano MA, Branch DW, Erkan D, APS ACTION (2021). Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry'). Lupus Sci Med, 9(1).
- Woller SC, Stevens SM, Kaplan D, Wang TF, Branch DW, Groat D, Wilson EL, Armbruster B, Aston VT, Lloyd JF, Rondina MT, Elliott CG (2021). Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial. Blood Adv, 6(6), 1661-1670.
- Givens M, Einerson BD, Allshouse AA, Bruno AM, Hammad I, Debbink MP, Branch DW, Silver RM (2021). Trends in Unplanned Peripartum Hysterectomy in the United States, 2009-2020. Obstet Gynecol, 139(3), 449-451.
- Sevim E, Zisa D, Andrade D, Sciascia S, Pengo V, Tektonidou MG, Ugarte A, Gerosa M, Belmont HM, Zamorano MAA, Fortin PR, Ji L, Efthymiou M, Cohen H, Branch DW, de Jesus GR, Andreoli L, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Roubey R, Bertolaccini ML, Erkan D, Barbhaiya M, APS ACTION Investigators (2020). Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository. Arthritis Care Res (Hoboken), 74(2), 324-335.
- Arslan E, Einerson BD, Zhang J, Zhang J, Branch DW (2021). The Effect of "Off Hours" on Maternal and Perinatal Outcomes in a Diverse U.S. Cohort. Am J Perinatol, 41(1), 89-97.
- de Azevedo Lopes E, Balbi GGM, Tektonidou MG, Pengo V, Sciascia S, Ugarte A, Belmont HM, Gerosa M, Fortin PR, Lopez-Pedrera C, Ji L, Cohen H, de Jess GR, Branch DW, Nalli C, Petri M, Rodriguez E, Kello N, Ros-Garcs R, Knight JS, Atsumi T, Willis R, Bertolaccini ML, Erkan D, Andrade D, APS ACTION (2021). Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository. Adv Rheumatol, 61(1), 64.
- Gkrouzman E, Sevim E, Finik J, Andrade D, Pengo V, Sciascia S, Tektonidou MG, Ugarte A, Chighizola CB, Belmont HM, Lopez-Pedrera C, Ji L, Fortin P, Efthymiou M, de Jesus GR, Branch DW, Nalli C, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Bertolaccini ML, Cohen H, Rand J, Erkan D, APS ACTION (2020). Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository. J Rheumatol, 48(4), 541-547.
- Carey AZ, Blue NR, Varner MW, Page JM, Chaiyakunapruk N, Quinlan AR, Branch DW, Silver RM, Workalemahu T (2021). A systematic review to guide future efforts in the determination of genetic causes of pregnancy loss. Front Reprod Health, 3.
- Paidas MJ, Tita ATN, Macones GA, Saade GA, Ehrenkranz RA, Triche EW, Streisand JB, Lam GK, Magann EF, Lewis DF, Dombrowski MP, Werner EF, Branch DW, Habli MA, Grotegut CA, Silver RM, Longo SA, Amon E, Cleary KL, How HY, Novotny SR, Grobman WA, Whiteman VE, Wing DA, Scifres CM, Sibai BM (2020). Prospective, randomized, double-blind, placebo-controlled evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia. Am J Obstet Gynecol, 223(5), 739.e1-739.e13.
- Zuily S, Clerc-Urms I, Bauman C, Andrade D, Sciascia S, Pengo V, Tektonidou MG, Ugarte A, Gerosa M, Michael Belmont H, Zamorano MAA, Fortin P, Ji L, Efthymiou M, Cohen H, Branch DW, Jesus GR, Nalli C, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Bertolaccini ML, Vega J, Wahl D, Erkan D, APS ACTION Investigators (2020). Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry. Lupus, 29(11), 1353-1363.
Review
- Chighizola CB, Willis R, Maioli G, Sciascia S, Andreoli L, Amengual O, Radin M, Gerosa M, Atsumi T, de Jesus G, Trespidi L, Branch DW, Caporali R, Andrade D, Roubey R, Petri M, Bertolaccini ML (2024). Deciphering the clinical significance of longitudinal antiphospholipid antibody titers. [Review]. Autoimmun Rev, 23(3), 103510.
- Knight JS, Branch DW, Ortel TL (2023). Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management. [Review]. BMJ, 380, e069717.
- Barbhaiya M, Zuily S, Ahmadzadeh Y, Amigo MC, Avcin T, Bertolaccini ML, Branch DW, de Jesus G, Devreese KMJ, Frances C, Garcia D, Guillemin F, Levine SR, Levy RA, Lockshin MD, Ortel TL, Seshan SV, Tektonidou M, Wahl D, Willis R, Naden R, Costenbader K, Erkan D, New APS Classification Criteria Collaborators (2021). Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria. [Review]. Arthritis Care Res (Hoboken), 73(10), 1490-1501.
- de Jess GR, Benson AE, Chighizola CB, Sciascia S, Branch DW (2020). 16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome. [Review]. Lupus, 29(12), 1601-1615.
- Welsch S, Branch DW (1997). Antiphospholipid syndrome in pregnancy. Obstetric concerns and treatment. [Review]. Rheum Dis Clin North Am, 23(1), 71-84.
Commentary
- Shainker SA, Silver RM, Modest AM, Hacker MR, Hecht JL, Salahuddin S, Dillon ST, Ciampa EJ, DAlton ME, Otu HH, Abuhamad AZ, Einerson BD, Branch DW, Wylie BJ, Libermann TA, Karumanchi SA (2020). Placenta accreta spectrum: biomarker discovery using plasma proteomics. Am J Obstet Gynecol, 223(3), 433.e1-433.e14.
- Einerson BD, Comstock J, Silver RM, Branch DW, Woodward PJ, Kennedy A (2020). In Reply. Obstet Gynecol, 136(3), 632.
- Einerson BD, Nelson RE, Sandoval G, Esplin MS, Branch DW, Metz TD, Silver RM, Grobman WA, Reddy UM, Varner M, Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD Maternal-Fetal Medicine Units MFMU Network (2020). Cost of Elective Labor Induction Compared With Expectant Management in Nulliparous Women. Obstet Gynecol, 136(1), 19-25.
- Einerson BD, Comstock J, Silver RM, Branch DW, Woodward PJ, Kennedy A (2020). Placenta Accreta Spectrum Disorder: Uterine Dehiscence, Not Placental Invasion. Obstet Gynecol, 135(5), 1104-1111.
- Arslan E, Branch DW (2019). Antiphospholipid syndrome: Diagnosis and management in the obstetric patient. Best Pract Res Clin Obstet Gynaecol, 64, 31-40.
- Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, DAnci KE (2020). 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Care Res (Hoboken), 72(4), 461-488.
- Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, DAnci KE (2020). 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol, 72(4), 529-556.
- Davis-Porada J, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Sawitzke A, Merrill JT, Buyon JP, Salmon JE (2020). Low frequency of flares during pregnancy and post-partum in stable lupus patients. Arthritis Res Ther, 22(1), 52.
- Branch DW (2019). What's new in obstetric antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program, 2019(1), 421-425.
- Radin M, Sciascia S, Erkan D, Pengo V, Tektonidou MG, Ugarte A, Meroni P, Ji L, Belmont HM, Cohen H, Ramires de Jess G, Branch DW, Fortin PR, Andreoli L, Petri M, Rodriguez E, Rodriguez-Pinto I, Knight JS, Atsumi T, Willis R, Gonzalez E, Lopez-Pedrera R, Rossi Gandara AP, Borges Gualhardo Vendramini M, Banzato A, Sevim E, Barbhaiya M, Efthymiou M, Mackie I, Bertolaccini ML, Andrade D, APS ACTION (2019). The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort. Semin Arthritis Rheum, 49(3), 464-468.
- Efthymiou M, Mackie IJ, Lane PJ, Andrade D, Willis R, Erkan D, Sciascia S, Krillis S, Bison E, Borges Galhardo Vendramini M, Romay-Penabad Z, Qi M, Tektonidou M, Ugarte A, Chighizola C, Belmont HM, Aguirre MA, Ji L, Branch DW, de Jesus G, Fortin PR, Andreoli L, Petri M, Cervera R, Rodriguez E, Knight JS, Atsumi T, Vega J, Sevim E, Bertolaccini ML, Pengo V, Cohen H, APS ACTION (2019). Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository. J Thromb Haemost, 17(12), 2069-2080.
- Odendaal J, Quenby S, Sammaritano L, Macklon N, Branch DW, Rosenwaks Z (2019). Immunologic and rheumatologic causes and treatment of recurrent pregnancy loss: what is the evidence? Fertil Steril, 112(6), 1002-1012.
- Hong S, Banchereau R, Maslow BL, Guerra MM, Cardenas J, Baisch J, Branch DW, Porter TF, Sawitzke A, Laskin CA, Buyon JP, Merrill J, Sammaritano LR, Petri M, Gatewood E, Cepika AM, Ohouo M, Obermoser G, Anguiano E, Kim TW, Nulsen J, Nehar-Belaid D, Blankenship D, Turner J, Banchereau J, Salmon JE, Pascual V (2019). Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy. J Exp Med, 216(5), 1154-1169.
- de Jess GR, Sciascia S, Andrade D, Barbhaiya M, Tektonidou M, Banzato A, Pengo V, Ji L, Meroni PL, Ugarte A, Cohen H, Branch DW, Andreoli L, Belmont HM, Fortin PR, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Nascimento IS, Rosa R, Erkan D, Levy RA, APS ACTION (2018). Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study. BJOG, 126(5), 656-661.
- Sciascia S, Willis R, Pengo V, Krilis S, Andrade D, Tektonidou MG, Ugarte A, Chighizola C, Branch DW, Levy RA, Nalli C, Fortin PR, Petri M, Rodriguez E, Rodriguez-Pinto I, Atsumi T, Nascimento I, Rosa R, Banzato A, Erkan D, Cohen H, Efthymiou M, Mackie I, Bertolaccini ML, APS ACTION (2019). The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis. Thromb Res, 175, 32-36.
- Einerson BD, Branch DW (2018). Surgical Management of Placenta Accreta Spectrum. Clin Obstet Gynecol, 61(4), 774-782.
- Zhang L, Troendle J, Branch DW, Hoffman M, Yu J, Zhou L, Duan T, Zhang J (2018). The expected labor progression after labor augmentation with oxytocin: A retrospective cohort study. PLoS One, 13(10), e0205735.
- Tebo AE, Willis R, Jaskowski TD, Guerra M, Pierangeli SS, Salmon J, Petri M, Branch DW (2016). Clinical significance and correlations between anti-β2 glycoprotein I IgA assays in antiphospholipid syndrome and/or systemic lupus erythematosus. Clin Chim Acta, 460, 107-13.
Letter
- Barbhaiya M, Zuily S, de Jesus G, Branch DW, Erkan D (2024). Reply. [Letter to the editor]. Arthritis Rheumatol.
- Bruno AM, Allshouse AA, Einerson BD, Campbell HM, Branch DW, Silver RM, Metz TD (2022). Trends in postpartum venous thromboembolism and chemical prophylaxis among insured US patients. [Letter to the editor]. Am J Obstet Gynecol MFM, 4(4), 100620.
- Harris EN, Goldsmith G, Pierangeli S, Gharavi A, Branch W (1995). Phospholipid binding antibodies warrant continued investigation. [Letter to the editor]. Blood, 85(8), 2276-7.
Ok I never leave Dr reviews ever. And I've seen my fair share. But I just loved Dr Branch because I could tell so obviously that he really reviewed my health history before our appt and he really thought about what to do for my care. I was so impressed by that and so relieved because it made me actually trust him!
I really appreciate his honesty and laid back energy. He listens and is willing to work with me through my pregnancy rather than tell me how my pregnancy gets to be with little to no input from me. He's knowledgeable and experienced without being arrogant and pushy. So far, out of 11 pregnancies, he is my favorite OB and I wish I had found him sooner.
Dr Branch is brilliant. He is very smart! Answers every question I have respectfully. Knowing I'm a scared mom he keeps his composure and eases my anxiety with educated answers. He doesn't guess he runs all the test to give me a solid answer. Will highly recommend to everyone in my position.
Very pleased with Dr. Branch's bedside manner. He also was a perfect mix of concerned but reassuring about my issues.
I felt like Dr Branch really took a lot of time and care with my appointment and I appreciated how much he tried to ensure that I felt comfortable and empowered to make decisions or take next steps.
Dr. Branch is a great doctor. He looks at each situation and determines the best course of action based on the specific patient and not ÒthatÕs how itÕs always done.Ó
I appreciated Dr Branch's approach to my care because, while direct, he was also friendly and respectful and really took the time to get to know me. Other doctors made judgements based off of appearances, but he digs deeper to really learn about his patients to offer the best care possible. I've only had one visit, but I'm confident Dr Branch will offer the care I've been looking for.
Dr. Branch is great at being proactive about my healthcare. He's got a plan for best and worst case scenarios and makes sure we are on the same page and I'm good with the plan. He follows the research and even showed me where I can look at the most updated research for my condition.
I did NOT like my experience. I seen Dr. Branch while my usual obstetrician was out of town. Dr. Branch made me feel belittled and dumb throughout my appointment. He did not have a good bedside manner, and his attitude was poor. As a first time mom, this was a terrible experience. He did not address any of my questions or concerns. This is especially concerning since I am a high risk pregnancy, and had concerning issues I wanted to address. He deflected my questions and turned them into talks about diet and exercise. I had to message my usual Doctor to get information from my appointment. I didn't even know I had been diagnosed with gestational hypertension until messaging my doctor for clarification. I will NOT be seeing Dr. Branch again, and I do not recommend him to others. His dismissive attitude should not be working with pregnant women, and he should probably retire.